| Metabolic engineering of volatile isoprenoids in plants and microbes CE Vickers, M Bongers, Q Liu, T Delatte, H Bouwmeester Plant, cell & environment 37 (8), 1753-1775, 2014 | 145 | 2014 |
| Synthetic multi-component enzyme mixtures for deconstruction of lignocellulosic biomass G Banerjee, S Car, JS Scott-Craig, MS Borrusch, M Bongers, JD Walton Bioresource technology 101 (23), 9097-9105, 2010 | 137 | 2010 |
| Knock-in/Knock-out (KIKO) vectors for rapid integration of large DNA sequences, including whole metabolic pathways, onto the Escherichia coli chromosome at … S Sabri, JA Steen, M Bongers, LK Nielsen, CE Vickers Microbial cell factories 12, 1-15, 2013 | 93 | 2013 |
| Systems analysis of methylerythritol-phosphate pathway flux in E. coli: insights into the role of oxidative stress and the validity of lycopene as an isoprenoid reporter … M Bongers, PK Chrysanthopoulos, JBYH Behrendorff, MP Hodson, ... Microbial cell factories 14, 1-16, 2015 | 28 | 2015 |
| Production of industrially relevant isoprenoid compounds in engineered microbes CE Vickers, JBYH Behrendorff, M Bongers, TCR Brennan, M Bruschi, ... Microorganisms in biorefineries, 303-334, 2015 | 28 | 2015 |
| α-Fucosidases with different substrate specificities from two species of Fusarium JM Paper, JS Scott-Craig, D Cavalier, A Faik, RE Wiemels, MS Borrusch, ... Applied microbiology and biotechnology 97, 5371-5380, 2013 | 23 | 2013 |
| Adaptation of hydroxymethylbutenyl diphosphate reductase enables volatile isoprenoid production M Bongers, J Perez-Gil, MP Hodson, L Schrübbers, T Wulff, MOA Sommer, ... Elife 9, e48685, 2020 | 20 | 2020 |
| Protocols for the production and analysis of isoprenoids in bacteria and yeast CE Vickers, M Bongers, SF Bydder, P Chrysanthopoulos, MP Hodson Hydrocarbon and Lipid Microbiology Protocols: Synthetic and Systems Biology …, 2016 | 16 | 2016 |
| Analysing intracellular isoprenoid metabolites in diverse prokaryotic and eukaryotic microbes M Plan, M Bongers, S Bydder, M Fabris, MP Hodson, E Kelly, J Krömer, ... Methods in Enzymology 670, 235-284, 2022 | 3 | 2022 |
| Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model V Iannone, AF Babu, J Lok, C Gómez-Gallego, G D'Auria, ... Molecular Metabolism 78, 101823, 2023 | 2 | 2023 |
| An engineered Escherichia coli Nissle 1917 increase the production of indole lactic acid in the gut C Dimopoulou, M Bongers, M Pedersen, MI Bahl, MOA Sommer, ... FEMS Microbiology Letters 370, fnad027, 2023 | 2 | 2023 |
| Drug-delivering bacteria MOA Sommer, K Sarup-Lytzen, M Bongers, RV Uribe, MVT Hof, ... WO Patent 2,023,175,124, 2023 | | 2023 |
| Therapeutic microbes M Bongers, FT FARFAN, M Sommer, F Neergaard, S Kammler US Patent App. 18/015,938, 2023 | | 2023 |
| Advanced microbiome therapeutics engineered to produce serotonin in vivo MOA Sommer, M Bongers, HH Wang, F Cusimano | | 2020 |
| Understanding metabolic control of carbon flux through the MEP pathway: a systems and synthetic biology approach CE Vickers, S Sabri, M Bongers, LK Nielsen AIBN, The University of Queensland, 2013 | | 2013 |
| Methods for treatment of non-alcoholic fatty liver diseases (nafld) using advanced microbiome therapeutics MOA Sommer, RV Uribe, M Bongers, H El-Nezamy, M Kolehmainen, ... | | |
| DTU DTU Library MOA Sommer, M Bongers, HH Wang, F Cusimano, MOA Sommer, ... | | |
